HELP · Insider Trading
Helus Pharma Inc. Common Stock
Every open-market purchase and sale reported by HELP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Greg Cavers | Chief Financial Officer | Buy | +3,000 | +$38.73K |
| 2026-10-01 | Eric H. L. So | Director | A | +248,000 | — |
| 2026-10-01 | Paul Glavine | Chief Growth Officer | A | +248,000 | — |
| 2026-09-21 | Michael Halstead | Chief Executive Officer | Buy | +100,000 | +$1.35M |
| 2026-09-11 | Paul Glavine | Chief Growth Officer | Buy | +100,000 | +$1.25M |
| 2026-09-11 | Eric H. L. So | Executive Chair | Buy | +100,000 | +$1.24M |
| 2026-09-11 | Paul Glavine | Chief Growth Officer | Buy | +100,000 | +$1.25M |
| 2026-09-10 | Eric H. L. So | Executive Chair | Buy | +100,000 | +$1.21M |
| 2026-09-10 | Paul Glavine | Chief Growth Officer | Buy | +100,000 | +$1.18M |
| 2026-09-09 | Paul Glavine | Chief Growth Officer | Buy | +90,000 | +$1.04M |
| 2026-09-09 | Eric H. L. So | Executive Chair | Buy | +95,000 | +$1.12M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Paul Glavine | Chief Growth Officer | 4,981,132 | $51.60M |
| Eric H. L. So | Executive Chair | 4,766,630 | $49.38M |
| Michael Halstead | Chief Executive Officer | 168,568 | $1.75M |
| Greg Cavers | Chief Financial Officer | 128,937 | $1.34M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HELP quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.